Kikuchi-fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy

Clinical Nuclear Medicine

Volumn 36, Issue 8, 2011, Pages 661-664

  Tsujikawa, Tetsuya ^a   Tsuchida, Tatsuro ^a   Imamura, Yoshiaki ^a   Kobayashi, Masato ^b   Asahi, Satoko ^a   Shimizu, Kazuhiro ^a   Tsuji, Kazunobu ^a   Okazawa, Hidehiko ^a   Kimura, Hirohiko ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

FDG; Kikuchi Fujimoto disease; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; CERVICAL LYMPHADENOPATHY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIKUCHI DISEASE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHODGKIN LYMPHOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; BIOLOGICAL TRANSPORT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HISTIOCYTIC NECROTIZING LYMPHADENITIS; HUMANS; LYMPHATIC DISEASES; LYMPHOMA, NON-HODGKIN; MALE; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL DISEASES;

EID: 79960228100     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31821a2878     Document Type: Article

References (25)

1. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes: a clinicopathological study. Acta Hematol Jpn. 1972;35:379-380.
2. Fujimoto Y, Kozima Y, Yamaguchi K. Cervical subacute necrotizing lymph¬adenitis: a new clinicopathologic entity. Naika. 1972;20:920-927.
3. Mosharraf-Hossain AK, Datta PG, Amin AS, et al. Kikuchi-Fujimoto disease presenting with fever, lymphadenopathy and dysphagia. J Pak Med Assoc. 2008;58:647-649.
4. Dorfman RF, Berry GJ. Kikuchi's histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis. Semin Diagn Pathol. 1988;5:329-345. (Pubitemid 19010597)
5. Kuo TT. Kikuchi's disease (histiocytic necrotizing lymphadenitis). A clini-copathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am JSurg Pathol. 1995;19:798-809.
6. Kwon SY, Kim TK, Kim YS, et al. CT findings in Kikuchi disease: analysis of 96 cases. Am JNeuroradiol. 2004;25:1099-1102.
7. Na DG, Chung TS, Byun HS, et al. Kikuchi disease: CT and MR findings. Am J Neuroradiol. 1997;18:1729-1732. (Pubitemid 30399776)
8. Miller WT Jr, Perez-Jaffe LA. Cross-sectional imaging of Kikuchi disease. JComput Assist Tomogr. 1999;23:548-551. (Pubitemid 29337147)
9. Liao AC, Chen YK. Cervical lymphadenopathy caused by Kikuchi disease: positron emission tomographic appearance. Clin Nucl Med. 2003;28:320-321. (Pubitemid 38281955)
10. Kim CH, Hyun OJ, Yoo IeR, et al. Kikuchi disease mimicking malignant lymphoma on FDG PET/CT. Clin Nucl Med. 2007;32:711-712. (Pubitemid 47294867)
11. Ito K, Morooka M, Kubota K F-18 FDG PET/CT findings showing lymph node uptake in patients with Kikuchi disease. Clin Nucl Med. 2009;34:821-822.
12. Kaicker S, Gerard PS, Kalburgi S, et al. PET-CT scan in a patient with Kikuchi disease. Pediatr Radiol. 2008;38:596-597.
13. 18F-FDG positron emission tomography/computed tomography of lymph node uptake. Jpn J Radiol. 2010;28:15-19.
14. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836-1839.
15. Geworski L, Knoop BO, de Cabrejas ML, et al. Recovery correction for quantitation in emission tomography: a feasibility study. Eur J Nucl Med. 2000;27:161-169. (Pubitemid 30102021)
16. Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomog¬raphy. Clin Cancer Res. 2000;6:3837-3844.
17. 18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res. 2002;8:3315-3323. (Pubitemid 35340704)
18. Degirmenci B, Wilson D, Laymon CM, et al. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglu-cose-PET/ computed tomography. Nucl Med Commun. 2008;29:614-622.
19. 18Fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggres¬sive non-Hodgkin's lymphoma. J Clin Oncol. 2005;23:4643-4651. (Pubitemid 46224066)
20. Tsujikawa T, Otsuka H, Morita N, et al. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma? Ann Nucl Med. 2008;22:23-30. (Pubitemid 351207663)
21. Ngeow JY, Quek RH, Ng DC, et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann Oncol. 2009;20:1543-1547.
22. Defawe OD, Hustinx R, Defraigne JO, et al. Distribution of F-18 fluorode-oxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med. 2005;30:340-341. (Pubitemid 40569787)
23. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and gran¬ulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
24. Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med. 2002;43:658-663. (Pubitemid 34507119)
25. Jones HA, Cadwalladar KA, White JF, et al. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of 18F-FDG PET images. J Nucl Med. 2002; 43:652-657 (Pubitemid 34507118)